Kiora Pharmaceuticals Advances Dual Phase 2 Retinal Trials with FDA-Backed Innovation
Dateline — Encinitas, California, November 8, 2024:Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced its third-quarter 2024 results alongside significant progress...
